Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Elomaa

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Genes, Chromosomes & Cancer|February 1, 1994
Dedifferentiated chondrosarcoma with t(9;22)(q34;q11-12)M Tarkkanen, T Wiklund, M Virolainen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Oral trofosfamide: an active drug in the treatment of soft-tissue sarcomaC Blomqvist, T Wiklund, M Pajunen, et al.
European Journal of Cardiology|May 1, 1979
Blood cadmium and plasma zinc measurements in acute myocardial infarctionM Ponteva, I Elomaa, H Bäckman, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1994
[Hodgkin disease and amyloidosis]A Jekunen, A Maiche, P Laurila, et al.
British Journal of Cancer|January 1, 1997
Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancerT Saarto, C Blomqvist, P Rissanen, et al.
Annals of Medicine|August 1, 1996
Results of treatment in testicular nonseminomaH Mäenpää, C Blomqvist, T Wiklund, et al.
Calcified Tissue International|August 3, 2005
Three-year oral clodronate treatment does not impair mineralization of newly formed bone--a histomorphometric studyT Saarto, T Taube, C Blomqvist, et al.
British Journal of Haematology|September 1, 1992
Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP)T Taube, K Franssila, L Risteli, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|May 1, 1989
Pharmacokinetics of clodronate in patients with metastatic breast cancerP J Pentikäinen, I Elomaa, A K Nurmi, et al.
British Journal of Cancer|September 19, 2002
Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinomaP Osterlund, A Orpana, I Elomaa, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Genes, Chromosomes & Cancer|February 1, 1994
Dedifferentiated chondrosarcoma with t(9;22)(q34;q11-12)M Tarkkanen, T Wiklund, M Virolainen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Oral trofosfamide: an active drug in the treatment of soft-tissue sarcomaC Blomqvist, T Wiklund, M Pajunen, et al.
European Journal of Cardiology|May 1, 1979
Blood cadmium and plasma zinc measurements in acute myocardial infarctionM Ponteva, I Elomaa, H Bäckman, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1994
[Hodgkin disease and amyloidosis]A Jekunen, A Maiche, P Laurila, et al.
British Journal of Cancer|January 1, 1997
Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancerT Saarto, C Blomqvist, P Rissanen, et al.
Annals of Medicine|August 1, 1996
Results of treatment in testicular nonseminomaH Mäenpää, C Blomqvist, T Wiklund, et al.
Calcified Tissue International|August 3, 2005
Three-year oral clodronate treatment does not impair mineralization of newly formed bone--a histomorphometric studyT Saarto, T Taube, C Blomqvist, et al.
British Journal of Haematology|September 1, 1992
Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP)T Taube, K Franssila, L Risteli, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|May 1, 1989
Pharmacokinetics of clodronate in patients with metastatic breast cancerP J Pentikäinen, I Elomaa, A K Nurmi, et al.
British Journal of Cancer|September 19, 2002
Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinomaP Osterlund, A Orpana, I Elomaa, et al.
Pageof 15